Assay News and Research

RSS

Researchers assess accuracy of lateral flow urine LAM test in detecting TB in HIV-positive people

Tuberculosis (TB) causes more deaths in people living with HIV than any other disease, with more than 300,000 deaths in 2017. When detected, early TB can be treated effectively; however, people with advanced HIV are at high risk of death, often without knowing they have TB.

22 Oct 2019

Development and assessment of NGS-based microsatellite instability assay

The assay has a clinically relevant five-day turnaround time and can be conducted on as little as 20 ng genomic DNA with a batch size of up to forty samples in a single run.

18 Oct 2019

Researchers uncover novel molecular clues for tumor aggression in neurofibromatosis type 1

Researchers at the Johns Hopkins Kimmel Cancer Center report that their study of tumor samples from people with the rare genetic syndrome neurofibromatosis type 1 (NF1) has uncovered novel molecular clues about which tumors are most likely to be aggressive in those with NF1

From Johns Hopkins Medicine 18 Oct 2019

Lyme vaccine on the horizon, says new study

Lyme disease is a dreaded disease caused by the bite of an infected tick. The only way to prevent it is by not getting bitten by the tick. However, this is not a practical recommendation, since even today about 300,000 thousand people are diagnosed with this infection, in the US alone, and over 100,000 in Europe, each year.

17 Oct 2019

New blood self-collection device quickly estimates a person's exposure to radiation

A University of Arizona College of Medicine - Phoenix research team has developed a blood self-collection device to quickly estimate a person's exposure to radiation in the event of a nuclear accident or attack.

16 Oct 2019

New rapid assay for Lyme disease could lead to a point-of-care diagnostic test

A study published in the Journal of Clinical Microbiology describes a new rapid assay for Lyme disease that could lead to a practical test for use by healthcare providers.

16 Oct 2019

Researchers develop affordable, reliable paper-based sensor to detect iron levels in fortified foods

Many low-income countries have turned to mass food fortification programs to address nutrient deficiencies in their populations. But many of these programs lack the resources needed to determine if the appropriate amount of nutrients is consistently present in those food products.

16 Oct 2019

Sphere Fluidics introduces Cyto-Cellect Human IgGK Detection Kit

Sphere Fluidics, introduced the Cyto-Cellect Human IgGK Detection Kit, to be used in conjunction with the Cyto-Mine® Single Cell Analysis System.

From Sphere Fluidics 16 Oct 2019

We are excited to release our latest software update with new Cyto-Mine functionalities!

The Cyto-Mine Studio Suite contains a collection of software to allow Cyto-Mine operation and data acquisition.

From Sphere Fluidics 16 Oct 2019

Advances in translational genetics unlocked by Bio-Rad technologies to be presented at ASHG 2019

Scientists will present 24 abstracts and three talks, highlighting research driven in part by Bio-Rad Laboratories' Droplet Digital PCR and single-cell ATAC-Seq (scATAC-Seq) technologies, at the 2019 American Society of Human Genetics Annual Meeting in Houston, October 15-19.

15 Oct 2019

Porvair Sciences to showcase new range of microplates at Lab Innovations 2019

Porvair Sciences will showcase its recently extended ranges of ultra-clean deep well and assay microplates for the first time in Europe at the forthcoming Lab Innovations 2019 exhibition.

From Porvair Sciences Limited 14 Oct 2019

Blood test can improve diagnosis and monitoring of aortic aneurysms

It is the 'silent killer' that claimed the life of Albert Einstein and affects 1% of men over the age of 65, but researchers at the University of Dundee believe they may be able to reduce the number of fatalities caused by abdominal aortic aneurysms.

11 Oct 2019

New microfluidic test can detect Lyme disease within 15 minutes

Some 300,000 people in the U.S. are diagnosed with Lyme disease every year. Caused by Borrelia burgdorferi and transmitted by the bite of infected Ixodes ticks, the disease if left untreated can cause serious neurologic, cardiac, and/or rheumatologic complications.

11 Oct 2019

Chewing gum to track fertility: Ovulaid

Infertility is a very potent cause of frustration and psychological problems such as anxiety and depression, as well as of high stress. Infertility or subfertility is defined by the World Health Organization as unsuccessful attempts to conceive for five or more years.

10 Oct 2019

Quanterix announces recipients of annual Accelerator Grant Program

Quanterix Corporation, a company digitizing biomarker analysis to advance the science of precision health, today announced Shelli Kesler, Ph.

From Quanterix 3 Oct 2019

Researchers create new material with antifungal and antitumor properties

A new material with antifungal and antitumor properties has been developed by researchers at the Center for Development of Functional Materials (CDMF), one of the Research, Innovation and Dissemination Centers (RIDCs) supported by São Paulo Research Foundation - FAPESP.

3 Oct 2019

New method can help detect melanoma cells in skin tumors

Melanoma is the least common but one of the most deadly skin cancers. It accounts for only about one percent of all cases globally, but the majority of skin cancer deaths.

30 Sep 2019

New blood test shows ability to accurately detect numerous types of cancer

A new blood test in development has shown ability to screen for numerous types of cancer with a high degree of accuracy, a trial of the test shows.

28 Sep 2019

NanoSurface Biomedical expands stem cell-based technologies with acquisition of Silene Biotech

Seattle biotech company NanoSurface Biomedical, Inc., a leading provider of biomimetic cell-based assay platforms and services, announced today that it has acquired Silene Biotech, a Seattle biotechnology company focused on stem cell banking and services.

From Curi Bio 26 Sep 2019

Personal Genome Diagnostics applies CE mark to PGDx elio tissue complete assay

Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics, today announced that it has applied the CE mark to the PGDx elio™ tissue complete assay.

26 Sep 2019